Cue Health Inc
NASDAQ:HLTH
Intrinsic Value
Cue Health, Inc. is a healthcare technology company which offers individuals, enterprises, government agencies, and healthcare providers access to lab-quality diagnostic testing at home, at work, or a... [ Read More ]
The intrinsic value of one HLTH stock under the Base Case scenario is 0.84 USD. Compared to the current market price of 0.19 USD, Cue Health Inc is Undervalued by 77%.
Valuation Backtest
Cue Health Inc
Run backtest to discover the historical profit from buying and selling HLTH stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of Cue Health Inc's business.
What risks and challenges
does Cue Health Inc face in the near future?
Summarize the latest earnings report
of Cue Health Inc.
Provide P/E
for Cue Health Inc and its competitors.
Balance Sheet Decomposition
Cue Health Inc
Current Assets | 192.2m |
Cash & Short-Term Investments | 111.5m |
Receivables | 1.3m |
Other Current Assets | 79.5m |
Non-Current Assets | 300.1m |
PP&E | 247.1m |
Intangibles | 21.5m |
Other Non-Current Assets | 31.4m |
Current Liabilities | 58.4m |
Accounts Payable | 11.1m |
Accrued Liabilities | 45m |
Other Current Liabilities | 2.3m |
Non-Current Liabilities | 45.1m |
Other Non-Current Liabilities | 45.1m |
Earnings Waterfall
Cue Health Inc
Revenue
|
199m
USD
|
Cost of Revenue
|
-182.3m
USD
|
Gross Profit
|
16.7m
USD
|
Operating Expenses
|
-286.8m
USD
|
Operating Income
|
-270.1m
USD
|
Other Expenses
|
13.5m
USD
|
Net Income
|
-256.6m
USD
|
Free Cash Flow Analysis
Cue Health Inc
What is Free Cash Flow?
HLTH Profitability Score
Profitability Due Diligence
Cue Health Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.
Score
Cue Health Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.
HLTH Solvency Score
Solvency Due Diligence
Cue Health Inc's solvency score is 59/100. The higher the solvency score, the more solvent the company is.
Score
Cue Health Inc's solvency score is 59/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HLTH Price Targets Summary
Cue Health Inc
According to Wall Street analysts, the average 1-year price target for HLTH is 1.08 USD with a low forecast of 0.51 USD and a high forecast of 2.1 USD.
Ownership
HLTH Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
HLTH Price
Cue Health Inc
Average Annual Return | -56.07% |
Standard Deviation of Annual Returns | 41.6% |
Max Drawdown | -99% |
Market Capitalization | 29.4m USD |
Shares Outstanding | 158 520 000 |
Percentage of Shares Shorted | 0.62% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Cue Health, Inc. is a healthcare technology company which offers individuals, enterprises, government agencies, and healthcare providers access to lab-quality diagnostic testing at home, at work, or at the point-of-care, all in a device. The company is headquartered in San Diego, California. The company went IPO on 2021-09-24. The firm has developed a platform, the Cue Integrated Care Platform, with a focus on user experience, convenience, and accuracy. The Cue Integrated Care Platform consists of hardware and software components: Cue Health Monitoring System includes Cue Reader, made up of a portable, durable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand a sample collection wand; Cue Data and Innovation Layer, with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, including its consumer-friendly Cue Health App and its Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, which allow for integrations with third-party applications and sensors. Its product offering is Cue COVID-19 Test. Its COVID-19 test, consist Cue Reader and COVID-19 Test Kit (Cue COVID-19 Cartridge and Cue Wand), is designed to detect SARS-CoV-2, the virus that causes COVID-19.
Contact
IPO
Employees
Officers
The intrinsic value of one HLTH stock under the Base Case scenario is 0.84 USD.
Compared to the current market price of 0.19 USD, Cue Health Inc is Undervalued by 77%.